-
Mashup Score: 1How CAR T Therapy Reimagines Cancer Treatment and More - 10 month(s) ago
Chimeric antigen receptor T cell therapy, commonly referred to as CAR T therapy, is an intervention that uses a patient’s own cells to fight their cancer. The therapy first received US Food and Drug Administration (FDA) approval in 2017. For some patients, this meant long term remission and even cures of their disease. And yet […]
Source: Inside Precision MedicineCategories: Future of Medicine, Latest HeadlinesTweet
-
Mashup Score: 0Vaccine Boost to CAR T Therapy May Help Address Solid Tumors - 10 month(s) ago
Researchers have used a vaccine that boosts CAR T therapy and may be a method that can help effectively treat solid tumors.
Source: Inside Precision MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Vaccine Boost to CAR T Therapy May Help Address Solid Tumors https://t.co/ySv142Y3D7 via @clinicalomics
-
-
Mashup Score: 0Phase I Study Aims To Determine Optimum Oncolytic Virus Dose for Recurrent Astrocytoma - 10 month(s) ago
Researchers have initiated a Phase I clinical trial to determine maximum tolerated dose of an oncolytic adenovirus in combination with fractionated stereotactic radiosurgery for patients with recurrent high-grade astrocytoma undergoing resection.
Source: Inside Precision MedicineCategories: General Medicine News, Latest HeadlinesTweet-
Our researchers are embarking on an exciting Phase 1 #ClinicalTrial that will study self-destructing #cancer cells as a treatment for patients with recurrent high-grade astrocytoma - the most common #BrainTumor. Read more: https://t.co/t4VagPfuQG
-
-
Mashup Score: 3Mayo Clinic to Deploy Google Cloud’s Generative AI Capabilities - 11 month(s) ago
Mayo Clinic will deploy Google Cloud’s its generative AI capabilities aimed at improving clinical workflows.
Source: Inside Precision MedicineCategories: Healthcare Professionals, Latest HeadlinesTweet-
Google Cloud announced today that Mayo Clinic will deploy its generative AI capabilities aimed at improving clinical workflows and facilitate clinicians in finding actionable information to help improve patient outcomes https://t.co/hSTdAIItSy https://t.co/Xbc6xj6CFj
-
-
Mashup Score: 2Telehealth-Based Clinical Trial for Pancreatic Cancer Is Launching - 11 month(s) ago
An entirely telehealth-based clinical trial in pancreatic cancer is being launched at Ohio State University. It will provide more patients with targeted therapy.
Source: Inside Precision MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Telehealth-Based Clinical Trial for Pancreatic Cancer Is Launching https://t.co/UuSz5JJtHI via @clinicalomics @PanCAN @lustgartenfdn
-
-
Mashup Score: 1AI Program Can Predict Future Health Outcomes for Patients - 11 month(s) ago
AI program NYUTron uses natural language processing and electronic health record data to complete many clinical predictive tasks.
Source: Inside Precision MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
AI Program Can Predict Future Health Outcomes for Patients https://t.co/pA48zK1i0u via @clinicalomics #AI
-
-
Mashup Score: 0Mayo Clinic to Deploy Google Cloud’s Generative AI Capabilities - 11 month(s) ago
Mayo Clinic will deploy Google Cloud’s its generative AI capabilities aimed at improving clinical workflows.
Source: Inside Precision MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Mayo Clinic to Deploy Google Cloud’s Generative AI Capabilities https://t.co/jD0KTXp2vk via @clinicalomics @Google @Verily @MayoClinic
-
-
Mashup Score: 1Study Defines Four Distinct Phenotypes of Long COVID - 11 month(s) ago
New data from the INSPIRE study has defined four phenotypes–or distinct symptom presentations–of Long COVID.
Source: Inside Precision MedicineCategories: Future of Medicine, Latest HeadlinesTweet-
RT @Inside_PM: New data from the INSPIRE study has defined four phenotypes of Long COVID. Learn more: https://t.co/nKXMwCvhgV https://t.co/…
-
-
Mashup Score: 0Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching - 11 month(s) ago
The Precision Cancer Consortium (PCC) has tapped Massive Bio and their AI analytics platform to optimize clinical trial matching.
Source: Inside Precision MedicineCategories: Hem/Oncs, Latest HeadlinesTweet-
Precision Cancer Consortium Taps Massive Bio’s AI Analytics for Clinical Trial Matching https://t.co/YIHdVhiCtJ via @clinicalomics
-
-
Mashup Score: 2Rare Mutations Confer Risk of Common Diseases - 11 month(s) ago
Rare, penetrant genetic mutations confer ten-fold the risk of everyday diseases compared with common variants in the same genes, AI-powered research has shown.
Source: Inside Precision MedicineCategories: Future of Medicine, Latest HeadlinesTweet-
RT @GenomeScience: Rare Mutations Confer Risk of Common Diseases #Genetics #Genomics #disease #Health https://t.co/u2LBZUf1Gq via @clinica…
-
RT @Inside_PM: How CAR T Therapy Reimagines Cancer Treatment and More. Read more: https://t.co/SaZC9yNzHT https://t.co/wSCDg1WMQw